» Articles » PMID: 20659685

Discovery and Characterization of the Laulimalide-microtubule Binding Mode by Mass Shift Perturbation Mapping

Overview
Journal Chem Biol
Publisher Elsevier
Date 2010 Jul 28
PMID 20659685
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Conventional approaches to site mapping have so far failed to identify the laulimalide binding site on microtubules. Using mass shift perturbation analysis and data-directed docking, we demonstrate that laulimalide binds to the exterior of the microtubule on beta-tubulin, in a region previously unknown to support ligand binding and well removed from the paclitaxel site. Shift maps for docetaxel and laulimalide are otherwise identical, indicating a common state of microtubule stability induced by occupancy of the distinct sites. The preferred binding mode highlights the penetration of the laulimalide side chain into a deep, narrow cavity through a unique conformation not strongly populated in solution, akin to a "striking cobra." This mode supports the development of a pharmacophore model and reveals the importance of the C1-C15 axis in the macrocycle.

Citing Articles

Kojic Acid Derivative as an Antimitotic Agent That Selectively Kills Tumour Cells.

Pichiri G, Piludu M, Congiu T, Grandi N, Coni P, Piras M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861074 PMC: 11768441. DOI: 10.3390/ph18010011.


Novobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity.

Syed A, Filandr F, Patterson-Fortin J, Bacolla A, Ravindranathan R, Zhou J Nucleic Acids Res. 2023; 51(18):9920-9937.

PMID: 37665033 PMC: 10570058. DOI: 10.1093/nar/gkad727.


Re-evaluation of the Fijianolide/Laulimalide Chemotype Suggests an Alternate Mechanism of Action for C-15/C-20 Analogs.

Morris J, Takahashi-Ruiz L, Persi L, Summers J, McCauley E, Chan P ACS Omega. 2022; 7(10):8824-8832.

PMID: 35309480 PMC: 8928504. DOI: 10.1021/acsomega.1c07146.


Computational Study on E-Hooks of Tubulins in the Binding Process with Kinesin.

Xie Y, Li L Int J Mol Sci. 2022; 23(4).

PMID: 35216151 PMC: 8877516. DOI: 10.3390/ijms23042035.


Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.

Jernigan F, Branstrom A, Baird J, Cao L, Dali M, Furia B Mol Cancer Ther. 2021; 20(10):1846-1857.

PMID: 34315764 PMC: 9398121. DOI: 10.1158/1535-7163.MCT-20-0774.